PMID- 9498303 OWN - NLM STAT- MEDLINE DCOM- 19980429 LR - 20190914 IS - 0166-2236 (Print) IS - 0166-2236 (Linking) VI - 21 IP - 2 DP - 1998 Feb TI - Matrix metalloproteinases and diseases of the CNS. PG - 75-80 AB - Matrix metalloproteinases (MMPs) are increasingly being implicated in the pathogenesis of several CNS diseases. In multiple sclerosis, MMPs could be responsible for the influx of inflammatory mononuclear cells into the CNS, contribute to myelin destruction and disrupt the integrity of the blood-brain barrier; in Alzheimer's disease, MMPs might mediate the deposition of amyloid beta-proteins; and MMPs are known to contribute to the invasiveness of malignant glioma cells and might regulate their angiogenic capacity. Nonetheless, MMPs could also have beneficial roles in recovery from CNS injury.Therefore, both the identity of the MMP and its cellular origin could determine whether disease pathogenesis or regeneration occurs, and thus synthetic MMP inhibitors might be valuable for treating some CNS diseases. FAU - Yong, V W AU - Yong VW AD - Dept of Oncology, University of Calgary, Alberta, Canada. FAU - Krekoski, C A AU - Krekoski CA FAU - Forsyth, P A AU - Forsyth PA FAU - Bell, R AU - Bell R FAU - Edwards, D R AU - Edwards DR LA - eng PT - Journal Article PT - Review PL - England TA - Trends Neurosci JT - Trends in neurosciences JID - 7808616 RN - EC 3.4.24.- (Metalloendopeptidases) SB - IM CIN - Trends Neurosci. 2001 Jan;24(1):8-9. PMID: 11261939 MH - Animals MH - Central Nervous System Diseases/*enzymology/pathology MH - Extracellular Matrix/*enzymology MH - Humans MH - Metalloendopeptidases/*metabolism RF - 50 EDAT- 1998/03/14 00:00 MHDA- 1998/03/14 00:01 CRDT- 1998/03/14 00:00 PHST- 1998/03/14 00:00 [pubmed] PHST- 1998/03/14 00:01 [medline] PHST- 1998/03/14 00:00 [entrez] AID - S0166223697011697 [pii] AID - 10.1016/s0166-2236(97)01169-7 [doi] PST - ppublish SO - Trends Neurosci. 1998 Feb;21(2):75-80. doi: 10.1016/s0166-2236(97)01169-7.